Med-tech startup Axial3D has announced the closing of a $15 million investment round led by a strategic investment of $10 million from Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing solutions. This is Stratasys’ first investment in Axial3D. The two companies also will be providing a joint offering to make patient-specific 3D printing solutions for hospitals and medical device manufacturers more accessible so it becomes a mainstream healthcare solution.
Personalized 3D printed anatomic models are used for pre-surgical planning and diagnostic use to improve patient outcomes while shortening the time spent in the operating room. They are also used in education and training, and medical device development. Creating a 3D printed model from a patient’s scan data normally takes several hours and requires a high level of technical expertise and expensive software licenses. Axial3D’s artificial intelligence-powered algorithms enable healthcare providers to segment CT and MRI scans for these models without significant investments in time, specialized skills and large upfront costs.
Stratasys’ J850 Digital Anatomy 3D printer enables medical customers to create models that not only accurately represent the appearance of human tissue but are also biomechanically realistic while suturing, cutting, or inserting and deploying medical devices.
Stratasys is a leading provider of 3D printers, materials and software for these anatomic models. The company’s J850 Digital Anatomy 3D printer enables medical customers to create models that not only accurately represent the appearance of human tissue but are also biomechanically realistic while suturing, cutting, or inserting and deploying medical devices. A range of Stratasys printers and materials have been validated and FDA 510(k) cleared with Axial3D software to produce anatomic models for pre-operative surgical planning and diagnostic use across multiple specialties.
Manufacturing on Demand
“We are proud to be partnering with Stratasys, and have always believed in their technology and, more importantly, their vision for 3D printing in healthcare,” said Axial3D CEO Roger Johnston. “We believe that to move the industry from early adopters to the mainstream, we need to improve the accessibility of models for healthcare so hospitals and medical device manufacturers can scale their patient-specific programs. Our joint offerings will be the positive, disruptive catalyst that medical 3D printing needs to address 3D printing accessibility.”
Stratasys has estimated the opportunity for medical 3D printing at approximately $2.8 billion.
“Many of the world’s leading hospitals are already benefiting from our MediJet and Digital Anatomy 3D printers for medical models,” said Dr. Yoav Zeif, CEO of Stratasys. “We believe that by working together with Axial3D, we can remove the barriers to entry for the remaining majority of hospitals in many countries around the world, dramatically growing the use of 3D printing in pre-surgical planning so it is truly a standard part of patient care. This is about providing a complete tailored solution for customers that is fast, automated and scalable.”
You might also like:
Nippon Gases is latest company to join ColdMetalFusion alliance: By joining the ColdMetalFusion Alliance, Nippon Gases becomes part of a network of major industry players. With its track record in delivering industrial, medical and specialty gas solutions as one of the global top 5 industrial gas suppliers, the company adds its wide array of capabilities from safety, sinter process know-how, chemistry, heat treatment as well as additive manufacturing with its own competence center. Thus, Nippon Gases can help customers scale up their operation from initial proof of concept to large-scale operation. Nippon Gases joins ColdMetalFusion Alliance likewise other partner from sintering, industrial manufacturing and 3D printing.
* This article is reprinted from 3D Printing Media Network. If you are involved in infringement, please contact us to delete it.
Author: VoxelMatters
Leave A Comment